Phase Ib/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.

被引：2
|
作者：
Wang, Andrew
Mcree, Autumn Jackson
Blackstock, A. William
O'Neil, Bert H.
Moore, Dominic T.
Calvo, Benjamin F.
Lee, Michael Sangmin
Murphy, Curran
Caliri, Kim
Tynan, Maureen T.
Senderowicz, Adrian Mario
Tepper, Joel E.
Sanoff, Hanna Kelly
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15144
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Pei-Long Sun
    Bing Li
    Qi-Fa Ye
    International Journal of Colorectal Disease, 2012, 27 : 1325 - 1332
  • [22] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Sun, Pei-Long
    Li, Bing
    Ye, Qi-Fa
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (10) : 1325 - 1332
  • [23] Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch colorectal cancer group
    Hospers, Geke A.
    Punt, Cornelis J. A.
    Tesselaar, Margot E.
    Cats, Annemieke
    Havenga, Klaas
    Leer, Jan W. H.
    Marijnen, Corrie A.
    Jansen, Edwin P.
    Van Krieken, Han H. J. M.
    Wiggers, Theo
    de Velde, Cornelis J. H. Van
    Mulder, Nanno H.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (10) : 2773 - 2779
  • [24] Phase II Study of Neoadjuvant Chemoradiotherapy With Oxaliplatin-Containing Regimen in Locally Advanced Rectal Cancer
    Baek, J. H.
    Lee, W. S.
    Shin, D. B.
    Sym, S. J.
    Kwon, K. A.
    Lee, K. C.
    Lee, S. H.
    Jung, D. H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S406 - S406
  • [25] A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
    Goto, Saori
    Hasegawa, Suguru
    Matsumoto, Takuya
    Hida, Koya
    Kawamura, Junichiro
    Yamanokuchi, Satoshi
    Yamaguchi, Takashi
    Matsusue, Ryo
    Kadokawa, Yoshio
    Kato, Shigeru
    Manaka, Dai
    Nishitai, Ryuta
    Nomura, Akinari
    Kanazawa, Akiyoshi
    Kawada, Kenji
    Kyogoku, Takahisa
    Sakai, Yoshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [26] Pilot study of intense neoadjuvant chemoradiotherapy for locally advanced rectal cancer: retrospective review of a phase II study
    Xu, Ben-hua
    Chi, Pan
    Guo, Jin-hua
    Guan, Guo-xian
    Tang, Tian-lan
    Yang, Ying-hong
    Chen, Ming-qiu
    Song, Jian-yuan
    Feng, Chang-yin
    TUMORI, 2014, 100 (02) : 149 - 157
  • [27] Preoperative chemoradiotherapy with capecitabine in locally advanced rectal cancer
    Stanculeanu, D.
    Scheusan, R.
    Cringeanu, A.
    Mitulescu, D.
    Mitulescu, G.
    Tache, A.
    Stefanescu, I
    ANNALS OF ONCOLOGY, 2007, 18 : VII122 - VII122
  • [28] Single institution phase II study of chemoradiotherapy with capecitabine in locally advanced rectal carcinoma.
    Moleron, R.
    Fernandez-Lizarbe, E.
    Veiras, M.
    Hernando, O.
    Garcia-Berrocal, M. I.
    De la Torre, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81
  • [29] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
  • [30] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJSO, 2010, 36 (03): : 244 - 250
12345